GDOC vs. XBI
Compare and contrast key facts about Goldman Sachs Future Health Care Equity ETF (GDOC) and SPDR S&P Biotech ETF (XBI).
GDOC and XBI are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. GDOC is an actively managed fund by Goldman Sachs. It was launched on Nov 9, 2021. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Performance
GDOC vs. XBI - Performance Comparison
Loading graphics...
GDOC vs. XBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GDOC Goldman Sachs Future Health Care Equity ETF | -8.12% | 10.74% | -1.66% | 4.60% | -17.12% | -2.77% |
XBI SPDR S&P Biotech ETF | 4.76% | 35.89% | 1.01% | 7.60% | -25.87% | -11.36% |
Returns By Period
In the year-to-date period, GDOC achieves a -8.12% return, which is significantly lower than XBI's 4.76% return.
GDOC
- 1D
- 2.76%
- 1M
- -5.94%
- YTD
- -8.12%
- 6M
- 2.88%
- 1Y
- 1.53%
- 3Y*
- 0.66%
- 5Y*
- —
- 10Y*
- —
XBI
- 1D
- 7.53%
- 1M
- 0.28%
- YTD
- 4.76%
- 6M
- 27.90%
- 1Y
- 58.08%
- 3Y*
- 19.00%
- 5Y*
- -1.29%
- 10Y*
- 9.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
GDOC vs. XBI - Expense Ratio Comparison
GDOC has a 0.75% expense ratio, which is higher than XBI's 0.35% expense ratio.
Return for Risk
GDOC vs. XBI — Risk / Return Rank
GDOC
XBI
GDOC vs. XBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Goldman Sachs Future Health Care Equity ETF (GDOC) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GDOC | XBI | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.08 | 2.02 | -1.93 |
Sortino ratioReturn per unit of downside risk | 0.25 | 2.70 | -2.45 |
Omega ratioGain probability vs. loss probability | 1.03 | 1.34 | -0.31 |
Calmar ratioReturn relative to maximum drawdown | 0.10 | 3.72 | -3.62 |
Martin ratioReturn relative to average drawdown | 0.31 | 13.98 | -13.67 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| GDOC | XBI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.08 | 2.02 | -1.93 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.04 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.29 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.20 | 0.36 | -0.56 |
Correlation
The correlation between GDOC and XBI is 0.75, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
GDOC vs. XBI - Dividend Comparison
GDOC's dividend yield for the trailing twelve months is around 0.35%, more than XBI's 0.34% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GDOC Goldman Sachs Future Health Care Equity ETF | 0.35% | 0.32% | 0.02% | 0.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.34% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Drawdowns
GDOC vs. XBI - Drawdown Comparison
The maximum GDOC drawdown since its inception was -31.01%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for GDOC and XBI.
Loading graphics...
Drawdown Indicators
| GDOC | XBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -31.01% | -63.89% | +32.88% |
Max Drawdown (1Y)Largest decline over 1 year | -14.57% | -13.39% | -1.18% |
Max Drawdown (5Y)Largest decline over 5 years | — | -55.04% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -63.89% | — |
Current DrawdownCurrent decline from peak | -15.86% | -26.17% | +10.31% |
Average DrawdownAverage peak-to-trough decline | -15.90% | -20.91% | +5.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.96% | 3.71% | +1.25% |
Volatility
GDOC vs. XBI - Volatility Comparison
The current volatility for Goldman Sachs Future Health Care Equity ETF (GDOC) is 6.04%, while SPDR S&P Biotech ETF (XBI) has a volatility of 11.60%. This indicates that GDOC experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| GDOC | XBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.04% | 11.60% | -5.56% |
Volatility (6M)Calculated over the trailing 6-month period | 11.22% | 19.25% | -8.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.63% | 29.24% | -10.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.83% | 32.23% | -13.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.83% | 32.15% | -13.32% |